key: cord-0777980-nsqyttd5
authors: Fitzpatrick, John C.; Comstock, Jordan M.; Longmuir, Reid A.; Donahue, Sean P.; Fitzpatrick, John M.; Bond, John B.
title: Cranial Nerve III Palsy in the Setting of COVID-19 Infection
date: 2021-02-19
journal: J Neuroophthalmol
DOI: 10.1097/wno.0000000000001160
sha: 1fd624eef11f72363ae9cae8a83edb2a6530179f
doc_id: 777980
cord_uid: nsqyttd5

nan

predisposing a patient to microvascular disease, the possibility of COVID-19-related third nerve palsy was postulated.

Multiple recent studies have reported an association between COVID-19 and cranial neuropathies. Several mechanisms have been theorized, including direct viral involvement, inflammatory response, immune mechanisms, and microvascular disease. Neurologic manifestations occurring because of an aberrant immune response to COVID-19 has been reported (1, 2) . A single case of pupil sparing oculomotor nerve palsy in the setting of the novel coronavirus was reported; however, the patient had multiple risk factors for vascular disease, including hypertension, diabetes, and cigarette smoking (3) . Direct viral invasion into the central nervous system through severe acute respiratory syndrome coronavirus 2 viral interaction with the angiotensin-converting enzyme 2 receptor in the nervous system leading to a cranial neuropathy has also been postulated (2) .

In our patient, the elevated D-dimer level suggests another possible etiology. Elevated concentrations of plasma D-dimer indicate recent or ongoing intravascular coagulation and fibrinolysis (4). A common theme seen in COVID-19 infection is coagulopathy (5) . COVID-19 patients have high venous thromboembolism rates, elevated D-dimer levels, and pulmonary microvascular thrombosis (6) . The occurrence of thrombotic phenomenon in COVID-19 has been supported by recent autopsy reports showing microthrombi in the pulmonary vasculature (7) . The mechanism of microthrombi formation in COVID-19 is unclear and may involve hypercoagulability, complement activation, or direct endothelial injury. Microthrombi formation secondary to COVID-19 infection should be considered as a possible etiology of the acute cranial nerve palsy as reported in this patient.

Miller Fisher Syndrome and polyneuritis cranialis in COVID-19

COVID-19 presenting with ophthalmoparesis from cranial nerve palsy

The 2019 novel coronavirus pneumonia with onset of oculomotor nerve palsy: a case study

A test in context: D-dimer

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Hyperinflammation and derangement of renin-angiotensinaldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis

Histopathologic findings in the explant lungs of a patient with COVID-19 treated with bilateral orthotopic lung transplant